DÃaz-Barriga, C.; Villanueva-Flores, F.; Quester, K.; Zárate-Romero, A.; Cadena-Nava, R.D.; Huerta-Saquero, A.
Asparaginase-Phage P22 Nanoreactors: Toward a Biobetter Development for Acute Lymphoblastic Leukemia Treatment. Pharmaceutics 2021, 13, 604.
https://doi.org/10.3390/pharmaceutics13050604
AMA Style
DÃaz-Barriga C, Villanueva-Flores F, Quester K, Zárate-Romero A, Cadena-Nava RD, Huerta-Saquero A.
Asparaginase-Phage P22 Nanoreactors: Toward a Biobetter Development for Acute Lymphoblastic Leukemia Treatment. Pharmaceutics. 2021; 13(5):604.
https://doi.org/10.3390/pharmaceutics13050604
Chicago/Turabian Style
DÃaz-Barriga, Cristina, Francisca Villanueva-Flores, Katrin Quester, Andrés Zárate-Romero, Ruben Dario Cadena-Nava, and Alejandro Huerta-Saquero.
2021. "Asparaginase-Phage P22 Nanoreactors: Toward a Biobetter Development for Acute Lymphoblastic Leukemia Treatment" Pharmaceutics 13, no. 5: 604.
https://doi.org/10.3390/pharmaceutics13050604
APA Style
DÃaz-Barriga, C., Villanueva-Flores, F., Quester, K., Zárate-Romero, A., Cadena-Nava, R. D., & Huerta-Saquero, A.
(2021). Asparaginase-Phage P22 Nanoreactors: Toward a Biobetter Development for Acute Lymphoblastic Leukemia Treatment. Pharmaceutics, 13(5), 604.
https://doi.org/10.3390/pharmaceutics13050604